Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aardvark Therapeutics, Inc. (AARD) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aardvark Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1774857.
Total stock buying since 2025: $23,160,000.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $72,966.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 1,447,500 | $23,160,000 | 0 | $0 | 17,209 | $72,966 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 0 | $0 | 0 | $0 | 17,209 | $72,966 |
2025-02 | 1,447,500 | $23,160,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-28 | Lee Tien-li (Chief Executive Officer) | Option Ex | 17,209 | 4.24 | 72,966 |
2025-02-14 | Sun Nelson (Chief Financial Officer) | Buy | 10,000 | 16.00 | 160,000 |
2025-02-14 | Chen Bihua | Buy | 187,500 | 16.00 | 3,000,000 |
2025-02-14 | Cui Xiangmin | Buy | 1,250,000 | 16.00 | 20,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AARD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aardvark Therapeutics, Inc. (symbol AARD, CIK number 1774857) see the Securities and Exchange Commission (SEC) website.